Abstract: Compounds of the formula
have a long duration of action and are useful for the treatment of chronic diseases resulting from the dysfunction of the serotonergic 5-HT1A system, such as schizophrenia and other psychotic disorders such as paranoia and mano-depressive illness.
Type:
Grant
Filed:
April 2, 2002
Date of Patent:
February 24, 2004
Assignee:
Wyeth
Inventors:
Wayne E. Childers, Michael G. Kelly, Lee E. Schechter, Sharon J. Rosenzweig-Lipson